POWERbreathe<sup>®</sup> Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis

Inspiratory muscle training may benefit respiratory function, cardiocirculatory parameters, quality of life and functionality in neuromuscular diseases. This pilot study aimed to demonstrate the POWERbreathe<sup>®</sup> inspiratory muscle training effects on maximum inspiratory pressure...

Full description

Bibliographic Details
Main Authors: Davinia Vicente-Campos, Sandra Sanchez-Jorge, J. L. Chicharro, Ricardo Becerro-de Bengoa-Vallejo, David Rodriguez-Sanz, Arianne R. García, Marie Rivoire, Astrid Benet, Sofía Boubekeur, César Calvo-Lobo
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/22/6655
_version_ 1797464948538867712
author Davinia Vicente-Campos
Sandra Sanchez-Jorge
J. L. Chicharro
Ricardo Becerro-de Bengoa-Vallejo
David Rodriguez-Sanz
Arianne R. García
Marie Rivoire
Astrid Benet
Sofía Boubekeur
César Calvo-Lobo
author_facet Davinia Vicente-Campos
Sandra Sanchez-Jorge
J. L. Chicharro
Ricardo Becerro-de Bengoa-Vallejo
David Rodriguez-Sanz
Arianne R. García
Marie Rivoire
Astrid Benet
Sofía Boubekeur
César Calvo-Lobo
author_sort Davinia Vicente-Campos
collection DOAJ
description Inspiratory muscle training may benefit respiratory function, cardiocirculatory parameters, quality of life and functionality in neuromuscular diseases. This pilot study aimed to demonstrate the POWERbreathe<sup>®</sup> inspiratory muscle training effects on maximum inspiratory pressure (PI<sub>max</sub>), heart rate (HR) and HR variability, as well as the quality of life impairment and functionality in patients with Amyotrophic Lateral Sclerosis (ALS). A pilot single-blinded, non-randomized controlled clinical trial was carried out. A total of 20T ALS patients were enrolled and divided into experimental (<i>n</i> = 10) and control (<i>n</i> = 10) groups. The experimental group received POWERbreathe<sup>®</sup> inspiratory muscle training in conjunction with usual care, and the control group received only usual care for 8 weeks. PI<sub>max</sub> (measured by POWERbreathe<sup>®</sup> KH1), HR and HR variability (evaluated by Polar H7), quality of life impairment [measured by the Amyotrophic Lateral Sclerosis Assessment Questionnaire—40 items (ALSAQ-40)] and functionality [assessed by the ALS Functional Rating Scale Revised (ALSFRS-R)] were collected at baseline and after 8 weeks of intervention. We detected statistically significant differences (<i>p</i> < 0.05) with an effect size ranging from medium to large (Cohen’s <i>d</i> = 0.72–1.37); relative to the control group, the experimental group had an increased PI<sub>max</sub> (mean difference = 10.80 cm H<sub>2</sub>O; 95% CI = 3.42–18.17) and ALSFRS-R score (mean difference = 5.30 points; 95% CI = −0.03–10.63) and reduced HR (mean difference = −8.80 beats-per-minute; 95% CI = −20.27–2.67) and R-R interval (mean difference = 78.30 ms; 95% CI = 2.89–153.70). POWERbreathe<sup>®</sup> inspiratory muscle training, in addition to usual care, may improve inspiratory strength and heart rate in patients with ALS. These results encourage larger and longer trials investigating potential clinically relevant benefits of inspiratory muscle training to these patients over the disease course.
first_indexed 2024-03-09T18:14:28Z
format Article
id doaj.art-2553af30f0ff419b9c6df3f6c546ef59
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T18:14:28Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-2553af30f0ff419b9c6df3f6c546ef592023-11-24T08:47:54ZengMDPI AGJournal of Clinical Medicine2077-03832022-11-011122665510.3390/jcm11226655POWERbreathe<sup>®</sup> Inspiratory Muscle Training in Amyotrophic Lateral SclerosisDavinia Vicente-Campos0Sandra Sanchez-Jorge1J. L. Chicharro2Ricardo Becerro-de Bengoa-Vallejo3David Rodriguez-Sanz4Arianne R. García5Marie Rivoire6Astrid Benet7Sofía Boubekeur8César Calvo-Lobo9Faculty of Health Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, SpainFaculty of Health Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, SpainGrupo FEBIO, Universidad Complutense de Madrid, 28040 Madrid, SpainFaculty of Nursing, Physical Therapy and Podiatry, Universidad Complutense de Madrid, 28040 Madrid, SpainFaculty of Nursing, Physical Therapy and Podiatry, Universidad Complutense de Madrid, 28040 Madrid, SpainFaculty of Health Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, SpainFaculty of Health Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, SpainFaculty of Health Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, SpainFaculty of Health Sciences, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, SpainFaculty of Nursing, Physical Therapy and Podiatry, Universidad Complutense de Madrid, 28040 Madrid, SpainInspiratory muscle training may benefit respiratory function, cardiocirculatory parameters, quality of life and functionality in neuromuscular diseases. This pilot study aimed to demonstrate the POWERbreathe<sup>®</sup> inspiratory muscle training effects on maximum inspiratory pressure (PI<sub>max</sub>), heart rate (HR) and HR variability, as well as the quality of life impairment and functionality in patients with Amyotrophic Lateral Sclerosis (ALS). A pilot single-blinded, non-randomized controlled clinical trial was carried out. A total of 20T ALS patients were enrolled and divided into experimental (<i>n</i> = 10) and control (<i>n</i> = 10) groups. The experimental group received POWERbreathe<sup>®</sup> inspiratory muscle training in conjunction with usual care, and the control group received only usual care for 8 weeks. PI<sub>max</sub> (measured by POWERbreathe<sup>®</sup> KH1), HR and HR variability (evaluated by Polar H7), quality of life impairment [measured by the Amyotrophic Lateral Sclerosis Assessment Questionnaire—40 items (ALSAQ-40)] and functionality [assessed by the ALS Functional Rating Scale Revised (ALSFRS-R)] were collected at baseline and after 8 weeks of intervention. We detected statistically significant differences (<i>p</i> < 0.05) with an effect size ranging from medium to large (Cohen’s <i>d</i> = 0.72–1.37); relative to the control group, the experimental group had an increased PI<sub>max</sub> (mean difference = 10.80 cm H<sub>2</sub>O; 95% CI = 3.42–18.17) and ALSFRS-R score (mean difference = 5.30 points; 95% CI = −0.03–10.63) and reduced HR (mean difference = −8.80 beats-per-minute; 95% CI = −20.27–2.67) and R-R interval (mean difference = 78.30 ms; 95% CI = 2.89–153.70). POWERbreathe<sup>®</sup> inspiratory muscle training, in addition to usual care, may improve inspiratory strength and heart rate in patients with ALS. These results encourage larger and longer trials investigating potential clinically relevant benefits of inspiratory muscle training to these patients over the disease course.https://www.mdpi.com/2077-0383/11/22/6655amyotrophic lateral sclerosisbreathing exercisesdisability evaluationheart ratemaximal respiratory pressuresquality of life
spellingShingle Davinia Vicente-Campos
Sandra Sanchez-Jorge
J. L. Chicharro
Ricardo Becerro-de Bengoa-Vallejo
David Rodriguez-Sanz
Arianne R. García
Marie Rivoire
Astrid Benet
Sofía Boubekeur
César Calvo-Lobo
POWERbreathe<sup>®</sup> Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis
Journal of Clinical Medicine
amyotrophic lateral sclerosis
breathing exercises
disability evaluation
heart rate
maximal respiratory pressures
quality of life
title POWERbreathe<sup>®</sup> Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis
title_full POWERbreathe<sup>®</sup> Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis
title_fullStr POWERbreathe<sup>®</sup> Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis
title_full_unstemmed POWERbreathe<sup>®</sup> Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis
title_short POWERbreathe<sup>®</sup> Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis
title_sort powerbreathe sup r sup inspiratory muscle training in amyotrophic lateral sclerosis
topic amyotrophic lateral sclerosis
breathing exercises
disability evaluation
heart rate
maximal respiratory pressures
quality of life
url https://www.mdpi.com/2077-0383/11/22/6655
work_keys_str_mv AT daviniavicentecampos powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis
AT sandrasanchezjorge powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis
AT jlchicharro powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis
AT ricardobecerrodebengoavallejo powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis
AT davidrodriguezsanz powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis
AT ariannergarcia powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis
AT marierivoire powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis
AT astridbenet powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis
AT sofiaboubekeur powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis
AT cesarcalvolobo powerbreathesupsupinspiratorymuscletraininginamyotrophiclateralsclerosis